PO037 / #1007 TRANSCUTANEOUS ELECTRICAL STIMULATION OF THE AURICULOTEMPORAL NERVE TO MODULATE SALIVARY GLANDS

Head and neck cancers represent the sixth most common cancer worldwide with approximately 630,000 new patients diagnosed annually1. Over that decade there has been a 20% increase in the incidence of HNC in the UK and worldwide. Up to 80% of patients will receive radiotherapy as part of their care2,3,4. Dry mouth (xerostomia) remains one of the most significant long-term effects on quality of life following radiotherapy5,6,7. The aim of the project is to develop a bespoke solution combing targeted optimal stimulation of the salivary glands, with minimal discomfort. The proposed system will incorporate a novel stimulating electrode, developed using COMSOL simulation, featuring focused activation with increased depth penetration and minimal discomfort.